Market Map
From robotic surgery to fetal monitoring, these startups are making medical devices that are on the fast track to US commercialization.
Launched in 2016, the US Food and Drug Administration’s Breakthrough Devices Program aims to incentivize innovation and reduce the time to market for medical devices meeting “breakthrough” criteria, such as a treatment targeting a life-threatening disease that could outperform current alternatives.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
